` 1726 (HKE Holdings Ltd) vs F9D (Boustead Singapore Ltd) Comparison - Alpha Spread

1726
vs
F9D

Over the past 12 months, has underperformed F9D, delivering a return of -10% compared to the F9D's 32% growth.

Valuation Comparison

S
GPCR Intrinsic Value
Not Available
PFE Intrinsic Value
28.11 USD
Undervaluation 15%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
S
Structure Therapeutics Inc
NASDAQ:GPCR
22.1 USD
Not Available Not Available Not Available
80.89 USD
266% Upside
Pfizer Inc
NYSE:PFE
24.03 USD
28.11 USD
Undervalued by 15%
23.75 USD
1% Overvalued
32.47 USD
26% Undervalued
29.14 USD
21% Upside

Financials Comparison

Growth Over Time
1726 vs F9D

1726
F9D
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
HKE Holdings Ltd
Revenue
Boustead Singapore Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
1726 vs F9D

1726
F9D
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
HKE Holdings Ltd
HKEX:1726
Boustead Singapore Ltd
SGX:F9D
What is Free Cash Flow?

Gross Margin

HKE Holdings Ltd
37.6%
F9D
44.3%

Operating Margin

HKE Holdings Ltd
-69.3%
F9D
19%

Net Margin

HKE Holdings Ltd
-64.7%
F9D
18%

FCF Margin

HKE Holdings Ltd
-77.6%
F9D
12.9%

ROE

HKE Holdings Ltd
-62.3%
F9D
18.8%

ROA

HKE Holdings Ltd
-37.9%
F9D
8.5%

ROIC

HKE Holdings Ltd
-101%
F9D
18%

ROCE

HKE Holdings Ltd
-65%
F9D
15.4%

Stocks Performance

Stocks Performance
1726 vs F9D

Loading

Performance Gap
1726 vs F9D

Loading
1726
F9D
Difference
www.alphaspread.com

Performance By Year
1726 vs F9D

Loading
1726
F9D
Add Stock
Unlock Full Access to Alpha Spread
Create Free Account